FEBS Letters
Volume 580, Issue 23 , Pages 5430-5435, 9 October 2006

Fundamental research is the basis for understanding and treatment of many human diseases

Edited by Gerrit van Meer

Department of Biochemistry and the Canadian Institutes of Health Research Group on the Molecular and Cell Biology of Lipids, University of Alberta, Edmonton, Alta., Canada T6G 2S2

Received 29 May 2006; received in revised form 2 June 2006; accepted 2 June 2006. published online 20 June 2006.

Abstract 

There are numerous examples of how fundamental research has been required to understand and treat human disease. This article focuses on three human diseases of lipid metabolism in which advancements in understanding and treatment would not have been possible without basic research. Fabry disease is an inherited metabolic disorder caused by the lack of a specific enzyme in glycosphingolipid catabolism. Cardiovascular disease is a complex and multifactorial disease but as many as half of the cases can be attributed to abnormal levels of plasma cholesterol. The incidence of liver disease is increasing due to the current epidemic of obesity. It is only recently that curiosity-driven research has yielded valuable insight into the mechanism by which liver disease evolves.

Keywords: Sphingolipids, Fabry disease, Glycosphingolipids, Cholesterol, Heart disease, Liver disease, Phosphatidylcholine, Muscular dystrophy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(06)00732-0

doi:10.1016/j.febslet.2006.06.025

FEBS Letters
Volume 580, Issue 23 , Pages 5430-5435, 9 October 2006